Analyst consensus rating
Rentokil Initial Analyst Rating: none
Direct answer
Rentokil Initial's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $32.03.
Forecast evidence checked September 8, 2026.
Get free Rentokil Initial email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $23.07
- Average price target
- $32.03
- High price target
- $35.00
- Low price target
- $26.70
- Low target gap
- +15.7%
- Target upside
- +38.8%
- High target gap
- +51.7%
- Target range width
- 36%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Rentokil Initial?
Rentokil Initial has a verified none consensus. The same dataset has an average price target of $32.03.
How far are Rentokil Initial's low and high targets from the recorded price?
The low target implies +15.7%, while the high target implies +51.7%.
How many analysts are included in Rentokil Initial's consensus?
The verified consensus includes 4 analysts.
How is Rentokil Initial's target upside or downside calculated?
The average target of $32.03 is divided by the recorded price of $23.07, then one is subtracted to produce +38.8%. This does not guarantee a future return.
When was Rentokil Initial's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.